Skip to main content
. 2015 Mar 1;31(3):318–325. doi: 10.1089/aid.2014.0059

Table 1.

Details of the JEQS2010 Panel

        DRM of PI DRM of RTI
Sample number Subtypea HIV RNA (log cp/ml) Type Major Minor Others NRTIs NNRTIs Others
014 B 3.07 Single D30N, M46I, I54V, V82A, N88D L10F, L33I, A71V, T74S I13V, L19I, A22V, E35D, M36I, R41K, I62V, L63P, Q92K, I93L M41L, L74I, V118I, M184V, T215Y None V35K, T39A, K43Q, K122E, I135T, I142T, Q207E, R211K
015 B 3.34 Single None None T12S, I15V, L63P None None K13R, K122E, T200I
016 B 2.83 Single None None T12S, I15V, L63P None None K13R, K122E, T200I
026 B 4.70 30% mix (M46ML, V82VT, L90LM)b (A71AV, T74TS)b (L10LH, I15VI, K20KR, E35ED, M36MI, N37NE, K43KR, R57RK, D60ED, I62IV, L63P, I64IV, I72IV, Q92EQ, I93IL)b (D67DN, K70KR, V118VI, M184MV, L210LF, T215TF, K219KE)b None (V35VT, T39TA, V60IV, K64KR, K122KE, I135TI, D123DE, M164VM, Q174H, D177DE, Q197QK, T200IA, I202IV, Q207E, R211KR, F214FL)b
028 B 4.82 10% mix            
029 B 5.09 50% mix            
a

Subtype was identified by the NCBI genotyping tool.

b

First amino acid harbored in the majority, second one in the minority (e.g., M46ML, the majority is “M” and the minority is “L”).

DRM, drug-resistance mutation; PI, protease inhibitor; RTI, reverse transcriptase inhibitor; NRTIs, nucleoside analogue reverse transcriptase inhibitors; NNRTIs, nonnucleoside analogue reverse transcriptase inhibitors; Single, single variant.